Estrogen reinforces barrier formation and protects against tumor necrosis factor alpha-induced barrier dysfunction in oral epithelial cells
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Epithelial barrier dysfunction is involved in the pathophysiology of periodontitis and oral lichen planus. Estrogens have been shown to enhance the physical barrier function of intestinal and esophageal epithelia, and we aimed to investigate the effect of estradiol (E2) on the regulation of physical barrier and tight junction (TJ) proteins in human oral epithelial cell monolayers. Methods: HOK-16B cell monolayers cultured on transwells were treated with E2, an estrogen receptor (ER) antagonist (ICI 182,780), tumor necrosis factor alpha (TNFα), or dexamethasone (Dexa), and the transepithelial electrical resistance (TER) was then measured. Cell proliferation was measured by the cell counting kit (CCK)-8 assay. The levels of TJ proteins and nuclear translocation of nuclear factor (NF)-κB were examined by confocal microscopy. Results: E2 treatment increased the TER and the levels of junctional adhesion molecule (JAM)-A and zonula occludens (ZO)-1 in a dose-dependent manner, without affecting cell proliferation during barrier formation. Treatment of the tight-junctioned cell monolayers with TNFα induced decreases in the TER and the levels of ZO-1 and nuclear translocation of NF-κB. These TNFα-induced changes were inhibited by E2, and this effect was completely reversed by co-treatment with ICI 182,780. Furthermore, E2 and Dexa presented an additive effect on the epithelial barrier function. Conclusions: E2 reinforces the physical barrier of oral epithelial cells through the nuclear ER-dependent upregulation of TJ proteins. The protective effect of E2 on the TNFα-induced impairment of the epithelial barrier and its additive effect with Dexa suggest its potential use to treat oral inflammatory diseases involving epithelial barrier dysfunction.
Abstract
Purpose: Epithelial barrier dysfunction is involved in the pathophysiology of periodontitis and oral lichen planus. Estrogens have been shown to enhance the physical barrier function of intestinal and esophageal epithelia, and we aimed to investigate the effect of estradiol (E2) on the regulation of physical barrier and tight junction (TJ) proteins in human oral epithelial cell monolayers. Methods: HOK-16B cell monolayers cultured on transwells were treated with E2, an estrogen receptor (ER) antagonist (ICI 182,780), tumor necrosis factor alpha (TNFα), or dexamethasone (Dexa), and the transepithelial electrical resistance (TER) was then measured. Cell proliferation was measured by the cell counting kit (CCK)-8 assay. The levels of TJ proteins and nuclear translocation of nuclear factor (NF)-κB were examined by confocal microscopy. Results: E2 treatment increased the TER and the levels of junctional adhesion molecule (JAM)-A and zonula occludens (ZO)-1 in a dose-dependent manner, without affecting cell proliferation during barrier formation. Treatment of the tight-junctioned cell monolayers with TNFα induced decreases in the TER and the levels of ZO-1 and nuclear translocation of NF-κB. These TNFα-induced changes were inhibited by E2, and this effect was completely reversed by co-treatment with ICI 182,780. Furthermore, E2 and Dexa presented an additive effect on the epithelial barrier function. Conclusions: E2 reinforces the physical barrier of oral epithelial cells through the nuclear ER-dependent upregulation of TJ proteins. The protective effect of E2 on the TNFα-induced impairment of the epithelial barrier and its additive effect with Dexa suggest its potential use to treat oral inflammatory diseases involving epithelial barrier dysfunction.
참고문헌 (37)
- Ivanov AI, "Cytoskeletal regulation of epithelial barrier function during inflammation", Am J Pathol, 177, pp.512~524 (2010)
- Belibasakis GN, "The expression of gingival epithelial junctions in response to subgingival biofilms", Virulence, 6, pp.704~709 (2015)
- Brunner PM, "Immunologic, microbial, and epithelial interactions in atopic dermatitis", Ann Allergy Asthma Immunol, 120, pp.34~41 (2018)
- Turner JR, "Intestinal mucosal barrier function in health and disease", Nat Rev Immunol, 9, pp.799~809 (2009)
- Roza Khalmuratova, "Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis", Immune Network, 17(1), pp.60~67 (2017), 대한면역학회[DOI]
- Swindle EJ, "Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches", J Allergy Clin Immunol, 124, pp.23~34 (2009)
- Choi YS, "P. gingivalis and dextran sulfate sodium induce periodontitis through the disruption of physical barriers in mice", Eur J Inflamm, 11, pp.419~431 (2013)
- Choi YS, "The presence of bacteria within tissue provides insights into the pathogenesis of oral lichen planus", Sci Rep, 6, pp.29186~ (2016)
- Katz J, "Hydrolysis of epithelial junctional proteins by P. gingivalis gingipains", Infect Immun, 70, pp.2512~2518 (2002)
- Ellen RP, "Insertional inactivation of the prtP gene of Treponema denticola confirms dentilisin's disruption of epithelial junctions", J Mol Microbiol Biotechnol, 2, pp.518~516 (2000)
- Damek-Poprawa M, "Cell junction remodeling in gingival tissue exposed to a microbial toxin", J Dent Res, 92, pp.518~523 (2013)
- Capaldo CT, "Cytokine regulation of tight junctions", Biochim Biophys Acta, 1788, pp.864~871 (2009)
- Takano K, "Role of tight junctions in signal transduction: an update", EXCLI J, 13, pp.1145~1162 (2014)
- Cui J, "Estrogen synthesis and signaling pathways during aging: from periphery to brain", Trends Mol Med, 19, pp.197~209 (2013)
- Looijer-van Langen M, "Estrogen receptor-β signaling modulates epithelial barrier function", Am J Physiol Gastrointest Liver Physiol, 300, pp.G621~G626 (2011)
- Braniste V, "Oestradiol decreases colonic permeability through oestrogen receptor beta-mediated up-regulation of occludin and junctional adhesion molecule-A in epithelial cells", J Physiol, 587, pp.3317~3328 (2009)
- Honda J, "Estrogen enhances esophageal barrier function by potentiating occludin expression", Dig Dis Sci, 61, pp.1028~1038 (2016)
- Välimaa H, "Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands", J Endocrinol, 180, pp.55~62 (2004)
- Park NH, "Immortalization of normal human oral keratinocytes with type 16 human papillomavirus", Carcinogenesis, 12, pp.1627~1631 (1991)
- Fujita T, "Irsogladine maleate regulates epithelial barrier function in tumor necrosis factor-α-stimulated human gingival epithelial cells", J Periodontal Res, 47, pp.55~61 (2012)
- Kielgast F, "Glucocorticoids regulate tight junction permeability of lung epithelia by modulating claudin 8", Am J Respir Cell Mol Biol, 54, pp.707~717 (2016)
- Ye D, "Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier", Am J Physiol Gastrointest Liver Physiol, 290, pp.G496~G504 (2006)
- Ma TY, "TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation", Am J Physiol Gastrointest Liver Physiol, 286, pp.G367~G376 (2004)
- Ma TY, "Mechanism of TNF-α modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression", Am J Physiol Gastrointest Liver Physiol, 288, pp.G422~G430 (2005)
- Sun WH, "Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation", Biochem Biophys Res Commun, 244, pp.691~695 (1998)
- Wen Y, "Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia", Brain Res, 1008, pp.147~154 (2004)
- Hsu SM, "17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factor-kappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells", Biochem Biophys Res Commun, 279, pp.47~52 (2000)
- Quaedackers ME, "Direct interaction between estrogen receptor alpha and NF-kappaB in the nucleus of living cells", Mol Cell Endocrino, 273, pp.42~50 (2007)
- Pelzer T, "Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta", Biochem Biophys Res Commun, 286, pp.1153~1157 (2001)
- Kalaitzidis D, "Transcription factor cross-talk: the estrogen receptor and NF-kappaB", Trends Endocrinol Metab, 16, pp.46~52 (2005)
- Ghisletti S, "17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization", Mol Cell Biol, 25, pp.2957~2968 (2005)
- Schaefer TM, "IL-1beta-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells", J Immunol, 175, pp.6509~6516 (2005)
- Vegeto E, "Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol", Proc Natl Acad Sci U S A, 100, pp.9614~9619 (2003)
- Miyagawa T, "Azithromycin recovers reductions in barrier function in human gingival epithelial cells stimulated with tumor necrosis factor-α", Arch Oral Biol, 62, pp.64~69 (2016)
- Pei-Wen Tsai, "Responses of Candida albicans to the Human Antimicrobial Peptide LL-37", The Journal of Microbiology, 52(7), pp.581~589 (2014), 한국미생물학회[DOI]
- Kulkarni NN, "Glucocorticoid dexamethasone down-regulates basal and vitamin D3 induced cathelicidin expression in human monocytes and bronchial epithelial cell line", Immunobiology, 221, pp.245~252 (2016)
- Park K, "The dietary ingredient, genistein, stimulates cathelicidin antimicrobial peptide expression through a novel S1P-dependent mechanism", J Nutr Biochem, 25, pp.734~740 (2014)